Glial gene–protein networks in neuroinflammation and disease transitions
Gene & Protein in Disease · 17.11.2026 · 026190014
DOI: 10.36922/gpd026190014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene & Protein in Disease, online erschienen am 17.11.2026. Verfasst von Moawiah M. Naffaa.
Abstract (Originalsprache)
Neuroinflammatory responses emerge from interacting molecular configurations rather than from uniform activation programs. This review examines how extracellular cues, receptor and sensor systems, intracellular signaling pathways, gene and protein effectors, and reciprocal microglia–astrocyte communication combine to shape glial function across neurological disease. Particular attention is given to nuclear factor kappa B, Janus kinase/signal transducer and activator of transcription 3 (STAT3), transforming growth factor beta, interferon-associated signaling, purinergic receptors, inflammasome pathways, ion and water transport systems, complement, and extracellular matrix regulation. Mechanistic comparisons show that pathway identity alone does not determine biological output: receptor context, interacting molecular partners, glial cell type, signal duration, disease phase, and local tissue environment alter whether related regulatory modules support surveillance, clearance, repair-associated remodeling, persistent inflammation, or tumor-associated niche organization. These principles are compared across Alzheimer’s disease, Parkinson’s disease, stroke, and glioblastoma, revealing substantial differences in initiating signals, temporal organization, cellular interactions, and evidentiary strength. Transcriptomic, proteomic, cerebrospinal fluid, blood, and spatial profiling further demonstrate that measurable glial states require interpretation by biological source and validation level. Experimental interventions targeting NLR family pyrin domain-containing protein 3, astrocytic water-channel systems, microglial populations, STAT3-associated signaling, and glioblastoma microenvironmental interactions illustrate that therapeutic effects depend not only on the molecular target but also on the glial and disease configuration in which it operates. A configuration-based interpretation of glial gene–protein networks therefore provides a mechanistic basis for comparing disease states, evaluating biomarkers, and matching molecular interventions to biologically defined therapeutic windows.
Zitieren
APA
Naffaa, M. M. (2026). Glial gene–protein networks in neuroinflammation and disease transitions. Gene & Protein in Disease, 0(0), 026190014. https://doi.org/10.36922/gpd026190014
Vancouver
Naffaa MM. Glial gene–protein networks in neuroinflammation and disease transitions. Gene & Protein in Disease. 2026;0(0):026190014. doi:10.36922/gpd026190014
BibTeX
@article{Naffaa2026,
author = {Naffaa, Moawiah M.},
title = {Glial gene–protein networks in neuroinflammation and disease transitions},
journal = {Gene & Protein in Disease},
year = {2026},
volume = {0},
number = {0},
pages = {026190014},
doi = {10.36922/gpd026190014}
}
EUVIMED